249 related articles for article (PubMed ID: 35543102)
21. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
22. Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients.
Kampman A; Wink F; Paap D; Carbo M; Siderius M; Kieskamp S; Maas F; Spoorenberg A; Arends S
Arthritis Care Res (Hoboken); 2024 Mar; 76(3):350-358. PubMed ID: 37781730
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J
Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
Callhoff J; Sieper J; Weiß A; Zink A; Listing J
Ann Rheum Dis; 2015 Jun; 74(6):1241-8. PubMed ID: 24718959
[TBL] [Abstract][Full Text] [Related]
25. Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Buß B; Freundlich B; Lange E; Alten R; Rudwaleit M; Sieper J
J Rheumatol; 2014 Oct; 41(10):2034-40. PubMed ID: 25028375
[TBL] [Abstract][Full Text] [Related]
26. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
27. Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
Dougados M; van der Heijde D; Tsai WC; Saaibi D; Marshall L; Jones H; Pedersen R; Vlahos B; Tarallo M
Health Qual Life Outcomes; 2020 Jan; 18(1):4. PubMed ID: 31900174
[TBL] [Abstract][Full Text] [Related]
28. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.
Poddubnyy D; Protopopov M; Haibel H; Braun J; Rudwaleit M; Sieper J
Ann Rheum Dis; 2016 Dec; 75(12):2114-2118. PubMed ID: 27125522
[TBL] [Abstract][Full Text] [Related]
29. Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort.
Ciurea A; Kissling S; Bürki K; Baraliakos X; de Hooge M; Hebeisen M; Papagiannoulis E; Exer P; Bräm R; Nissen MJ; Möller B; Kyburz D; Andor M; Distler O; Scherer A; Micheroli R
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35110365
[TBL] [Abstract][Full Text] [Related]
30. Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial.
Van den Bosch F; Wei JC; Nash P; Blanco FJ; Graham D; Zang C; Arthur E; Borlenghi C; Tsekouras V; Vlahos B; Deodhar A
J Rheumatol; 2023 Apr; 50(4):478-487. PubMed ID: 36379575
[TBL] [Abstract][Full Text] [Related]
31. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
[TBL] [Abstract][Full Text] [Related]
32. Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis.
Llop M; Rios Rodriguez V; Redeker I; Sieper J; Haibel H; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2019 May; 21(1):126. PubMed ID: 31126334
[TBL] [Abstract][Full Text] [Related]
33. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
[TBL] [Abstract][Full Text] [Related]
34. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis.
Başkan BM; Sivas F; Inal EE; Duran S; Elverici E; Ozoran K; Bodur H
Clin Rheumatol; 2010 Jan; 29(1):65-70. PubMed ID: 19813046
[TBL] [Abstract][Full Text] [Related]
36. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
Kang KY; Jung JY; Hong YS; Ju JH; Park SH
Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
[TBL] [Abstract][Full Text] [Related]
37. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
38. Clinical Relevance of Axial Radiographic Damage in Axial Spondyloarthritis: Evaluation of Functional Consequences by an Objective Electronic Device.
Kiefer D; Braun J; Chatzistefanidi V; Kiltz U; Adolf D; Schwarze I; Kabelitz M; Lange U; Brandt-Jürgens J; Stemmler E; Sartingen S; Baraliakos X
J Rheumatol; 2023 Nov; 50(11):1422-1429. PubMed ID: 37061230
[TBL] [Abstract][Full Text] [Related]
39. Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Maksymowych WP; Claudepierre P; de Hooge M; Lambert RG; Landewé R; Molto A; van der Heijde D; Bukowski JF; Jones H; Pedersen R; Szumski A; Vlahos B; Dougados M
Arthritis Res Ther; 2021 Jan; 23(1):43. PubMed ID: 33514428
[TBL] [Abstract][Full Text] [Related]
40. Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.
Rios Rodriguez V; Hermann KG; Weiß A; Listing J; Haibel H; Althoff C; Proft F; Behmer O; Sieper J; Poddubnyy D
Arthritis Rheumatol; 2019 May; 71(5):722-728. PubMed ID: 30625261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]